CD8+ T cells play a central role in mediating anti-tumor immunity by exoSTING as demonstrated by the abrogation of anti-tumor activity following selective antibody-mediated depletion of these cells (Fig. 2f). This evidence concerns the gene CD8A and neoplasm.